194 filings
Page 2 of 10
6-K
bijtn
29 Feb 24
Current report (foreign)
7:35am
6-K
zzy9e3 6a2
20 Feb 24
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
7:32am
6-K
xj82tn9lbx38uk1s g1t
7 Feb 24
Current report (foreign)
4:30pm
6-K
we0fb0
7 Feb 24
Current report (foreign)
8:30am
6-K
hxxka86ls3
6 Feb 24
Evaxion Announces Closing of $15 Million Public Offering
8:30am
424B4
80yzg7yzgc5keylt9e
5 Feb 24
Prospectus supplement with pricing info
9:09am
6-K
u9wkw 6tmm8
5 Feb 24
Securities Purchase Agreement
7:00am
EFFECT
4wo3pjv
2 Feb 24
Notice of effectiveness
12:15am
6-K
vz94zv6
1 Feb 24
Evaxion Biotech Announces Pricing of $15 Million Public Offering
9:20am
F-1/A
dqczry 4774g
31 Jan 24
Registration statement (foreign) (amended)
5:10pm
F-1/A
gk4445 loj
31 Jan 24
Registration statement (foreign) (amended)
9:26am
F-1/A
ej2ahw2
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
CORRESP
lxbrtj g4nwnpol
30 Jan 24
Correspondence with SEC
12:00am
6-K
c2hpcwbnk
26 Jan 24
Current report (foreign)
4:30pm
6-K
bhg4tjucs5uf977v01vq
24 Jan 24
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
2:11pm
6-K
i5y7z2
22 Jan 24
Evaxion Announces Completion of ADS Ratio Change
4:45pm
UPLOAD
tnu6t9d zutr7iqiwm
18 Jan 24
Letter from SEC
12:00am
F-1
dczz4i0n d3o
12 Jan 24
Registration statement (foreign)
5:17pm
6-K
lya3l
12 Jan 24
Current report (foreign)
9:24am
6-K
tj60 bp62h1
10 Jan 24
Notice of Extraordinary General Meeting
8:44am